Michael Celano

Insider Reports History

Location
Bethlehem, PA
Signature
/s/ Jennifer Johansson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Celano:

Company Role Class Num Shares Value Price $ Report Date Ownership
Larimar Therapeutics, Inc. Chief Financial Officer Common Stock 178,181 $1,557,302 $8.74 22 Jan 2025 Direct
ORASURE TECHNOLOGIES INC Director Common Stock 111,823 $915,327 $8.19 12 Aug 2022 Direct
Larimar Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 205,111 22 Jan 2025 Direct

Insider Reports Filed by Michael Celano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LRMR Larimar Therapeutics, Inc. 22 Jan 2025 2 $0 4 Chief Financial Officer 24 Jan 2025, 16:15
LRMR Larimar Therapeutics, Inc. 17 Jan 2024 2 $0 4 Chief Financial Officer 19 Jan 2024, 16:32
LRMR Larimar Therapeutics, Inc. 17 May 2023 1 +$18,632 4 Chief Financial Officer 18 May 2023, 14:13
LRMR Larimar Therapeutics, Inc. 31 Jan 2023 2 $0 4 Chief Financial Officer 02 Feb 2023, 19:16
LRMR Larimar Therapeutics, Inc. 16 Sep 2022 1 +$100,000 4 Chief Financial Officer 19 Sep 2022, 07:00
OSUR ORASURE TECHNOLOGIES INC 12 Aug 2022 1 +$53,916 4 Director 16 Aug 2022, 16:01
OSUR ORASURE TECHNOLOGIES INC 16 May 2022 2 +$112,156 4 Director 18 May 2022, 16:06
LRMR Larimar Therapeutics, Inc. 10 May 2022 1 $0 4 Chief Financial Officer 12 May 2022, 20:28
LRMR Larimar Therapeutics, Inc. 18 Jan 2022 1 $0 4 Chief Financial Officer 20 Jan 2022, 18:19
OSUR ORASURE TECHNOLOGIES INC 17 May 2021 2 +$110,605 4 Director 19 May 2021, 16:05